Potential pitfall: Irritable bowel syndrome (IBS) is a common disorder and can mimic the symptoms of ovarian cancer. Helpful hint: NICE NG12 guidelines recommend carrying out appropriate tests for ovarian cancer in any woman of 50 or over who has experienced symptoms...
Cancer Keys: Faecal Calprotectin
Latest from the Blog
World Cancer Day 2021
4th February 2021 The 4th of February 2021 marks World Cancer Day 2021. This year, the theme #IAmAndIWill encourages us to recognise our own commitments to improving cancer outcomes. GatewayC now has over 19 free online cancer education courses which can help primary...
Related Posts
Cancer Keys: COVID-19 and Neutropenic Sepsis
Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...
Cancer Keys: Pancreatic Cancer and New-Onset Diabetes
Potential pitfall: In the early course of the disease, pancreatic cancer may not cause any signs or symptoms. However, sudden onset diabetes in groups of patients for whom this would be unexpected can be an early indicator. Helpful hint: NICE NG12 guidelines recommend...

Potential pitfall:
Faecal calprotectin testing is an incredibly sensitive investigation for detecting the presence of inflammation. It is raised in a wide variety of conditions including malignancy, inflammatory bowel disease and alcohol misuse. It is therefore not good at defining either the site or the cause of inflammation.
Helpful hint:
The NICE DG11 guidance recommends faecal calprotectin testing as an option to support clinicians with the differential diagnosis of inflammatory bowel disease (IBD), or irritable bowel syndrome (IBS), in adults with recent onset lower gastrointestinal symptoms for whom specialist assessment is being considered, if:
-
- cancer is not suspected, having considered the risk factors (for example, age) described in the NICE guideline on suspected cancer and
- appropriate quality assurance processes and locally agreed care pathways are in place for the testing.
Cancer Keys are brought to you by GatewayC.
Download this Cancer Key here
Read the NICE NG12 guidance here
Access GatewayC’s Faecal Immunochemical Test (FIT) course here

Latest from the Blog
Cancer Keys: Ovarian Cancer and New-Onset Irritable Bowel Syndrome
Potential pitfall: Irritable bowel syndrome (IBS) is a common disorder and can mimic the symptoms of ovarian cancer. Helpful hint: NICE NG12 guidelines recommend carrying out appropriate tests for ovarian cancer in any woman of 50 or over who has experienced symptoms...
World Cancer Day 2021
4th February 2021 The 4th of February 2021 marks World Cancer Day 2021. This year, the theme #IAmAndIWill encourages us to recognise our own commitments to improving cancer outcomes. GatewayC now has over 19 free online cancer education courses which can help primary...
Related Posts
Cancer Keys: COVID-19 and Neutropenic Sepsis
Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy). Helpful hint: NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this...
Cancer Keys: Pancreatic Cancer and New-Onset Diabetes
Potential pitfall: In the early course of the disease, pancreatic cancer may not cause any signs or symptoms. However, sudden onset diabetes in groups of patients for whom this would be unexpected can be an early indicator. Helpful hint: NICE NG12 guidelines recommend...